Top Markets
Coin of the day
Graybug Vision, Inc. Graybug Vision, Inc.

Graybug Vision, Inc.

GRAY
Clasificación en acciones #35305
Graybug Vision, Inc. is a biopharmaceutical company currently in its clinical... Graybug Vision, Inc. is a biopharmaceutical company currently in its clinical development phase, dedicated to creating treatments for conditions affecting the eye's retina and optic nerve. Its flagship therapeutic, GB-102, is an injectable microparticle formulation of sunitinib administered directly into the eye. This compound is progressing through Phase I/IIa and IIb clinical trials for wet age-related macular degeneration, while also undergoing Phase IIa trials for diabetic macular edema. Furthermore, GB-102 is being explored as a treatment for diabetic retinopathy. The company's pipeline also includes GB-401, an intraocular implant designed to deliver a beta-adrenergic receptor inhibitor, intended for the management of primary open-angle glaucoma. Initially established as Graybug LLC in 2011, the firm rebranded to Graybug Vision, Inc. in 2016 and is headquartered in Redwood City, California.
Precio por acción
$2.70
Última sincronización: 2023-05-17
Capitalización bursátil
$4.13M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Graybug Vision, Inc. (GRAY)

Categoría

Historial de desdoblamientos de acciones de Graybug Vision, Inc. (GRAY)
La acción Graybug Vision, Inc. (símbolo: GRAY) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 16, 2026.
Una acción GRAY comprada antes de Aug 16, 2026 equivaldría hoy a 0 acciones GRAY.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE